XML 215 R86.htm IDEA: XBRL DOCUMENT v3.25.4
Restatement of Previously Issued Financial Statements - Schedule of Consolidated Statements of Cash Flows (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Schedule of Consolidated Statements of Cash Flows [Line Items]                    
Net loss $ (21,501,957) $ (577,023) $ (689,155) $ (2,018,531) $ (14,269,147) $ (405,129) $ (22,768,135) $ (16,692,807) $ (17,815,307) $ (1,841,899)
Adjustments to reconcile net loss to net cash used in operating activities.                    
Amortization expense             215 76 103
Depreciation expense 43,800     2,247     128,200 3,858 27,113 103
Changes in operating assets and liabilities                    
Prepaid expenses             10,971 93,486 145,106 (77,215)
Advance to a related company             97,353 98,771 10,289
Deposits             (43,877) 102,327 (127,664)
Other receivables             283 (47,355) (45,306) (34,183)
Interests payable             42,214 17,424 23,657 23,380
Other payables and accrued expenses             131,377 193,371 702,538 160,597
Payable to directors                 2,296,915
Net cash (used in) provided by operating activities             (1,813,635) (2,578,471) (3,026,529) 410,323
Cash flows from investing activities:                    
Purchases of property and equipment             (29,469) (1,271,734) (1,438,033) (1,598)
Net cash used in investing activities             (32,277) (1,271,734) (1,438,033) (1,598)
Cash flows from financing activities:                    
Payments of deferred merger costs                   (700,810)
Net cash provided by (used in) financing activities             1,568,062 4,059,793 4,706,973 (700,810)
Effect of exchange rate changes             (19,491) (122,809) 104,814 68,394
Net change in cash             (297,341) 86,779 347,225 (223,691)
Cash, beginning of the period     $ 348,655     1,430 348,655 1,430 1,430 225,121
Cash, end of the period $ 51,314     88,209     $ 51,314 88,209 348,655 1,430
As previously reported [Member]                    
Schedule of Consolidated Statements of Cash Flows [Line Items]                    
Net loss               (14,156,518)   (2,340,661)
Adjustments to reconcile net loss to net cash used in operating activities.                    
Amortization expense               323,772   431,593
Depreciation expense               3,870   103
Changes in operating assets and liabilities                    
Prepaid expenses               125,596   (77,215)
Advance to a related company               97,882   10,289
Deposits                   (127,664)
Other receivables               (47,018)   (34,183)
Interests payable               17,433   23,380
Other payables and accrued expenses                   119,147
Payable to directors                   1,704,724
Net cash (used in) provided by operating activities               (4,347,079)   (290,487)
Cash flows from investing activities:                    
Purchases of property and equipment               (1,271,043)   (1,598)
Net cash used in investing activities               (1,271,043)   (1,598)
Cash flows from financing activities:                    
Payments of deferred merger costs                  
Net cash provided by (used in) financing activities               5,704,901  
Effect of exchange rate changes                   68,394
Net change in cash               86,779   (223,691)
Cash, beginning of the period           1,430   1,430 1,430 225,121
Cash, end of the period       88,209       88,209   1,430
Adjustments [Member]                    
Schedule of Consolidated Statements of Cash Flows [Line Items]                    
Net loss               (2,536,289)   498,762
Adjustments to reconcile net loss to net cash used in operating activities.                    
Amortization expense               (323,696)   (431,593)
Depreciation expense               (12)  
Changes in operating assets and liabilities                    
Prepaid expenses               (32,110)  
Advance to a related company               (529)  
Deposits                  
Other receivables               (337)  
Interests payable               (9)  
Other payables and accrued expenses                   41,450
Payable to directors                   592,191
Net cash (used in) provided by operating activities               1,768,608   700,810
Cash flows from investing activities:                    
Purchases of property and equipment               (691)  
Net cash used in investing activities               (691)  
Cash flows from financing activities:                    
Payments of deferred merger costs                   (700,810)
Net cash provided by (used in) financing activities               (1,645,108)   (700,810)
Effect of exchange rate changes                  
Net change in cash                
Cash, beginning of the period            
Cash, end of the period